CVS Health Announces Split of Pharmacy and Insurance Units

CVS Health, the largest healthcare conglomerate in the United States with a valuation of $117 billion, has officially announced plans to divide its operations. The company intends to separate its retail pharmacy network from its health insurance and benefits divisions. This strategic move marks the end of an era where healthcare providers expanded into massive, vertically integrated conglomerates.

In a statement released on Wednesday, the company detailed the structure of the split. The 9,000 physical pharmacies, in-store clinics, and the mail-order prescription division will form a new entity named CVS Pharmacy. The remaining organization will retain the CVS Health name and house major insurance provider Aetna, the pharmacy benefits manager Caremark, and other services that offer home visits and primary care to older adults.

The decision follows significant pressure from lawmakers and regulators who have long expressed concern over the dominance of major healthcare players. CVS Health, along with UnitedHealth Group and Cigna, controls approximately 80% of the market. Critics argue that this concentration of power has contributed to rising medical costs. CVS Health itself generated over $400 billion in revenue in the previous year, highlighting the sheer scale of its operations.

A growing political movement against healthcare gigantism has influenced this corporate restructuring. Arkansas and Tennessee have recently passed laws designed to prevent large healthcare companies from simultaneously managing prescription benefits and operating retail or mail-order pharmacies. Other states are considering similar restrictions to curb the influence of these giants.

Jeremiah Moore, a Republican state representative in Arkansas who sponsored the state bill, commented on the issue last week in an interview with Politico. He stated that the average American citizen is tired of being pushed around by monopolistic companies. Moore described the situation as crony capitalism, noting that these entities have bent the rules to benefit their own bottom lines for far too long.

At the federal level, legislation aimed at an antitrust crackdown has been introduced by Missouri Republican Senator Josh Hawley and Massachusetts Senator Elizabeth Warren. Hawley characterized the proposed bill as a major step toward restoring transparency in the healthcare system. He emphasized that the goal is to make healthcare more affordable for every American.

David Joyner, the chief executive and chair of CVS, will lead the healthcare solutions business following the split. In a statement, Joyner noted that the company’s history is defined by proactively evolving to stay ahead of trends. He explained that the current environment requires delivering more affordability, greater access, and a simpler experience for patients.

This announcement represents a sharp reversal in the company’s stance. CVS Health previously opposed legislative efforts to break up the healthcare giant. A company spokesman had argued that such measures would open the door to private equity firms stripping the US healthcare system for parts. The shift in strategy suggests a recognition of the changing political and market landscape.

The move comes after a series of acquisitions that saw CVS Health expand into nearly every corner of the healthcare system. The trend began in 2018 when CVS and Aetna merged in a $70 billion deal. Rivals like UnitedHealth and Cigna also adopted similar models, combining insurers, pharmacy benefits, and mail-order businesses under one roof.

Despite its size, CVS Health has struggled to meet investor expectations for growth. The company’s share price fell to $44 in late 2024, though it has since rebounded. The planned breakup is scheduled to be completed in early 2028.